![Linda Powers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Linda Powers
Directeur Général chez
NORTHWEST BIOTHERAPEUTICS, INC.
Fortune : 7 M $ au 31/05/2026
Profil
Linda F.
Powers is the founder of Toucan Capital Corp., founded in 1997, serving as Managing Director.
Current jobs include Chairman, President, CEO & Chief Financial Officer at Northwest Biotherapeutics, Inc. since 2011; Director at Q Therapeutic Products, Inc.; Director at VetStem, Inc.; Director at The Trudeau Institute; and Director at Moffitt Technology Corp.
Former jobs include Director at Pepgen Corp.; Managing Director at Toucan Capital Fund II LP from 2001 to 2010; Independent Director at Q Therapeutics, Inc. from 2004 to 2015; Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc.; Director-Task Force at National Academy of Sciences; Director at Aster Insights; Director at Toucan Capital Fund III LP from 2010 to 2018; Director at The Chinese Biopharmaceutical Association; Director at The Rosalind Franklin Society; Director at The Genetics Policy Institute Inc; Director at Maryland Stem Cell Research Commission; and Adjunct Professor at Georgetown University.
Education includes undergraduate studies at Princeton University and graduate studies at Harvard Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/11/2025 | 29 411 759 ( 1,79 % ) | 7 M $ | 31/05/2026 |
Postes actifs de Linda Powers
| Sociétés | Poste | Début |
|---|---|---|
| NORTHWEST BIOTHERAPEUTICS, INC. | Directeur Général | 08/06/2011 |
Toucan Capital Corp.
 Toucan Capital Corp. Investment ManagersFinance Toucan Capital seeks investment opportunities in companies located in the United States primarily in the Mid Atlantic region. The firm targets companies operating in the fields of life science and advanced technology sectors. It provides equity financing for seed, early and later stage capital requirements with an investment size of USD 0.1 to 5 million. It acts as a lead investor. The firm makes follow-on investments. | Fondateur | 01/01/1997 |
Vet-Stem, Inc.
 Vet-Stem, Inc. Pharmaceuticals: MajorHealth Technology Develops and tests veterinary pharmaceuticals | Directeur/Membre du Conseil | - |
The Trudeau Institute
 The Trudeau Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non profit research institute for infectious diseases | Directeur/Membre du Conseil | - |
Moffitt Technology Corp. | Directeur/Membre du Conseil | - |
Q Therapeutic Products, Inc.
 Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel products to treat debilitating and fatal diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Linda Powers
| Sociétés | Poste | Fin |
|---|---|---|
Toucan Capital Fund III LP
 Toucan Capital Fund III LP Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | 01/01/2018 |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system | Directeur/Membre du Conseil | 11/12/2015 |
Toucan Capital Fund II LP
 Toucan Capital Fund II LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01/01/2010 |
| ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Linda Powers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Northwest Biotherapeutics, Inc.
 Northwest Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes immunotherapy products | Health Technology |
Pepgen Corp.
 Pepgen Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes products for the prevention, treatment of autoimmune and viral disorders | Health Technology |
Toucan Capital Fund II LP
Toucan Capital Fund II LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Q Therapeutic Products, Inc.
Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel products to treat debilitating and fatal diseases | Commercial Services |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system | Health Technology |
Toucan Capital Corp.
Toucan Capital Corp. Investment ManagersFinance Toucan Capital seeks investment opportunities in companies located in the United States primarily in the Mid Atlantic region. The firm targets companies operating in the fields of life science and advanced technology sectors. It provides equity financing for seed, early and later stage capital requirements with an investment size of USD 0.1 to 5 million. It acts as a lead investor. The firm makes follow-on investments. | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Commercial Services |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
Vet-Stem, Inc.
Vet-Stem, Inc. Pharmaceuticals: MajorHealth Technology Develops and tests veterinary pharmaceuticals | Health Technology |
The Trudeau Institute
The Trudeau Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non profit research institute for infectious diseases | Commercial Services |
Moffitt Technology Corp. | |
Aster Insights
 Aster Insights Miscellaneous Commercial ServicesCommercial Services Provides scientific and clinical intelligence solutions for oncology drug discovery | Commercial Services |
Toucan Capital Fund III LP
Toucan Capital Fund III LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
The Chinese Biopharmaceutical Association | |
The Rosalind Franklin Society
 The Rosalind Franklin Society Miscellaneous Commercial ServicesCommercial Services Engages in recognizes and celebrates the contributions of outstanding women in the life sciences & disciplines | Commercial Services |
The Genetics Policy Institute Inc
 The Genetics Policy Institute Inc Miscellaneous Commercial ServicesCommercial Services Operates as promoter and defender of stem cell research | Commercial Services |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maryland Stem Cell Research Commission
 Maryland Stem Cell Research Commission General GovernmentGovernment Operates as a Maryland stem cell research commission | Government |
